Canadian Blood and Marrow Transplant Group
Cure Stems From Here
Small Budget Research Grants
Small Budget Research Grant Program
The CBMTG Small Budget Research Grant Program provides funds for eligible individuals to undertake research on topics that will have a relevance to blood and marrow transplantation. The primary aim of the grant program is to promote pilot and/or feasibility studies. Projects which require augmented funding or bridge financing may also be considered. The grant is for a maximum of CAD$5,000 depending on the nature and budget of the project. The grant is offered once per year, to a maximum of 4 individuals, subject to approval by the CBMTG Executive Committee.
The CBMTG Small Budget Research Grants are restricted to current CBMTG members only. Join today!
Congratulation to the Recipients of the 2010 Small Budget Research Grants!
2010 accepted grants include:
"Autologous and allogeneic stem cell transplantation in the management of transformed indolent lymphoma" (Dr. John Kuruvilla, Princess Margaret Hospital)
"Prolifer Stem Assay: An improved method to measure stem cell proliferative potential" (Ms. Brenda Letcher, Canadian Blood Services)
"Filtering of Stem Cell Products: Is There a Significant Cell Loss?" (Dr. Kristjan Paulson, CancerCare Manitoba)
"Psychological distress, coping style and dyadic adjustments in patients undergoing hematopoietic stem cell transplant and their spouses- moving towards psychosocial health and wellbeing: a longitudinal study" (Dr. Brenda Sabo, Dalhousie University)
CBMTG would like to thank Otsuka for their support through an unrestricted educational grant.
2009 accepted grants include:
“Pertussis Problems: An investigation into pertussis vaccine immunogenicity after bone marrow transplantation in pediatric patients” (Dr. Conrad Fernandez, IWK Health Centre)
“Long-term cryopreservation of hematopoietic stem cells for autologous transplantation” (Dr. Donna Hogge, BC Cancer Agency)
“Proteomics of Allogenic Blood or Marrow Grafts: A Pilot Study to Optimize Specimen Preparation for Mass Spectrometric Adjunct Studies for Patients in Prospective CBMTG Studies of Graft Source” (Dr. Harold Atkins, The Ottawa Hospital)
“Preclinical development of a natural killer cell line KHYG-1 as a novel therapeutic agent for high risk AML” (Dr. Armand Keating, Princess Margaret Hospital)
“A prospective Study of the multidimensional quality of life in pediatric HSCT Recipients” (Dr. John Doyle, Hospital for Sick Children)
Applications for the 2011 program will be accepted in Spring 2011.
